BAY-94-9392

N/A

Report date: 2025/11/27 15:47:59
NME

Base Information

Drug NameBAY-94-9392
Drug Alias Name[18F]FSPGflorilglutamic acid (18F)BAY-94-9392BAY94-9392[18F]-FSPG +[7] 
ClassificationSmall moleculesRadiation-emitting products > Radioactive diagnostic agentDiagnostic agent (In vivo) > Radionuclide Imaging agent +[5] 
Mechanisms of ActionRadionuclide imaging enhancersCystine/glutamate transporter binders
TargetsCystine/glutamate transporter
Therapy Area/IndicationsSmoking CessationSarcoidosisMyocarditis +[23] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesGermanySouth Korea
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesPiramalNational Cancer InstituteBayer AG +[4] 
China Registration ClassN/A

Develop Information

Active CompaniesNational Cancer InstituteThe University Of Texas MD Anderson Cancer Center
Inactive CompaniesStanford UniversityLife Molecular Imaging Sa
Active IndicationsSmoking CessationSolitary Pulmonary NoduleNeoplasm Metastasis +[8] 
Inactive IndicationsSarcoidosisMyocarditisFallopian Tube Neoplasms +[15] 

Other Information

ATC CodeN/A
Related LinksN/A